Back
Biogen, Inc. Vs. Apogee Therapeutics, Inc. Industry Stock Comparison
Buy
53
BIIB
Biogen, Inc.
Last Price:
$155.47
Seasonality Move:
6.79%
Buy
51
APGE
Apogee Therapeutics, Inc.
Last Price:
$54.77
Seasonality Move:
31.04%
Buy
53
Biogen, Inc. (BIIB)
is a Buy
Is Biogen, Inc. a Buy, Sell or Hold?
-
The current Biogen, Inc. [BIIB] share price is $155.51. The Score for BIIB is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Apogee Therapeutics, Inc. (APGE)
is a Buy
Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Apogee Therapeutics, Inc. [APGE] share price is $54.71. The Score for APGE is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
APGE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIIB Stock Price Chart
What is Biogen, Inc.'s stock price today?
-
The Biogen, Inc. share price today is $155.51Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
APGE Stock Price Chart
What is Apogee Therapeutics, Inc.'s stock price today?
-
The Apogee Therapeutics, Inc. share price today is $54.71The current trend is moderately bullish and APGE is experiencing slight buying pressure.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 60.95 | Buy |
| Chaikin Money Flow: | 793533 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (145.41 - 153.03) | Buy |
| Bollinger Bands (100): | (129.55 - 147.69) | Buy |
APGE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.62 | Buy |
| Relative Strength Index (14 RSI): | 59.36 | Buy |
| Chaikin Money Flow: | 167543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.82 - 57.66) | Buy |
| Bollinger Bands (100): | (35.37 - 49.33) | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 152.27 | Buy |
| 20-day SMA: | 148.86 | Buy |
| 50-day SMA: | 146.06 | Buy |
| 200-day SMA: | 135.51 | Buy |
| 8-day EMA: | 152.86 | Buy |
| 20-day EMA: | 150.26 | Buy |
| 50-day EMA: | 145.99 | Buy |
| 200-day EMA: | 145.03 | Buy |
APGE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.22 | Sell |
| 20-day SMA: | 54.93 | Sell |
| 50-day SMA: | 45.64 | Buy |
| 200-day SMA: | 39.88 | Buy |
| 8-day EMA: | 54.96 | Sell |
| 20-day EMA: | 53.27 | Buy |
| 50-day EMA: | 48.15 | Buy |
| 200-day EMA: | 42.55 | Buy |
Biogen, Inc. Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.30 per share, and an increase next year of $0.12 per share.
Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.28 per share, and a decrease next year of $0.58 per share.
Biogen, Inc. Technical Analysis
| Oct 27 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 3 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 27 | 28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Therapeutics, Inc. Technical Analysis
| Oct 27 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 3 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 27 | 28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||